Literature DB >> 18398035

Detection and quantitation of N'-nitrosonornicotine in human toenails by liquid chromatography-electrospray ionization-tandem mass spectrometry.

Irina Stepanov1, Stephen S Hecht.   

Abstract

Specific biomarkers of tobacco carcinogen uptake are critical for investigations of the role of tobacco smoke exposure in human cancers. Two new biomarkers of human exposure to tobacco-specific carcinogens have been recently developed by our research group: urinary N'-nitrosonornicotine (NNN) and toenail 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL). In this study, we report the presence of NNN in human toenails. Toenails of 17 smokers were analyzed for total NNN. Mean total NNN level in these samples was 4.63 +/- 6.48 fmol/mg toenail and correlated with previously reported total NNAL (r = 0.96; P < 0.0001), total nicotine (r = 0.48; P < 0.05), and total cotinine (r = 0.87; P < 0.0001). An interesting finding was that amounts of NNN in smokers' toenails were generally higher than those of total NNAL. The ratio of toenail NNN to NNAL averaged 2.8, whereas the previously reported ratio between these biomarkers in smokers' urine was 0.1. NNN was also found in toenail samples from 12 nonsmokers, averaging 0.35 +/- 0.16 fmol/mg and positively correlating with toenail cotinine (r = 0.58; P = 0.05). The results of this study show the feasibility of quantifying NNN in human toenails, providing a potentially useful new biomarker of tobacco carcinogen exposure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398035      PMCID: PMC3874877          DOI: 10.1158/1055-9965.EPI-07-2711

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  26 in total

Review 1.  Drugs in nails: physiology, pharmacokinetics and forensic toxicology.

Authors:  A Palmeri; S Pichini; R Pacifici; P Zuccaro; A Lopez
Journal:  Clin Pharmacokinet       Date:  2000-02       Impact factor: 6.447

2.  Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.

Authors:  S S Hecht; S G Carmella; M Chen; J F Dor Koch; A T Miller; S E Murphy; J A Jensen; C L Zimmerman; D K Hatsukami
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

3.  Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke.

Authors:  K E Anderson; S G Carmella; M Ye; R L Bliss; C Le; L Murphy; S S Hecht
Journal:  J Natl Cancer Inst       Date:  2001-03-07       Impact factor: 13.506

4.  Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use.

Authors:  Stephen S Hecht; Steven G Carmella; Ming Ye; Ky-anh Le; Joni A Jensen; Cheryl L Zimmerman; Dorothy K Hatsukami
Journal:  Cancer Res       Date:  2002-01-01       Impact factor: 12.701

5.  Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children.

Authors:  S S Hecht; M Ye; S G Carmella; A Fredrickson; J L Adgate; I A Greaves; T R Church; A D Ryan; S J Mongin; K Sexton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-11       Impact factor: 4.254

6.  Mass spectrometric quantitation of nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human toenails.

Authors:  Irina Stepanov; Rachel Feuer; Joni Jensen; Dorothy Hatsukami; Stephen S Hecht
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-12       Impact factor: 4.254

7.  Identification of cocaine analytes in fingernail and toenail specimens.

Authors:  D Garside; J D Ropero-Miller; B A Goldberger; W F Hamilton; W R Maples
Journal:  J Forensic Sci       Date:  1998-09       Impact factor: 1.832

Review 8.  Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer.

Authors:  Stephen S Hecht
Journal:  Carcinogenesis       Date:  2002-06       Impact factor: 4.944

9.  Relationship of human toenail nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol to levels of these biomarkers in plasma and urine.

Authors:  Irina Stepanov; Stephen S Hecht; Bruce Lindgren; Peyton Jacob; Margaret Wilson; Neal L Benowitz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-07       Impact factor: 4.254

10.  Endogenous formation of N'-nitrosonornicotine in F344 rats in the presence of some antioxidants and grape seed extract.

Authors:  Diana Porubin; Stephen S Hecht; Zhong-ze Li; Maria Gonta; Irina Stepanov
Journal:  J Agric Food Chem       Date:  2007-07-19       Impact factor: 5.279

View more
  17 in total

1.  Differential Sphingolipid and Phospholipid Profiles in Alcohol and Nicotine-Derived Nitrosamine Ketone-Associated White Matter Degeneration.

Authors:  Emine B Yalcin; Kavin Nunez; Ming Tong; Suzanne M de la Monte
Journal:  Alcohol Clin Exp Res       Date:  2015-12       Impact factor: 3.455

2.  Self-reported Tobacco use does not correlate with carcinogen exposure in smokers with head and neck cancer.

Authors:  Samir S Khariwala; Steven G Carmella; Irina Stepanov; Dipankar Bandyopadhyay; Heather H Nelson; Bevan Yueh; Dorothy K Hatsukami; Stephen S Hecht
Journal:  Laryngoscope       Date:  2015-04-15       Impact factor: 3.325

3.  Biomarkers of Tobacco Exposure: Summary of an FDA-Sponsored Public Workshop.

Authors:  Cindy M Chang; Selvin H Edwards; Aarthi Arab; Arseima Y Del Valle-Pinero; Ling Yang; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-11-09       Impact factor: 4.254

4.  Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers.

Authors:  Jian-Min Yuan; Aleksandar D Knezevich; Renwei Wang; Yu-Tang Gao; Stephen S Hecht; Irina Stepanov
Journal:  Carcinogenesis       Date:  2011-07-06       Impact factor: 4.944

5.  Elevated levels of 1-hydroxypyrene and N'-nitrosonornicotine in smokers with head and neck cancer: A matched control study.

Authors:  Samir S Khariwala; Steven G Carmella; Irina Stepanov; Patricia Fernandes; Amy Anne Lassig; Bevan Yueh; Dorothy Hatsukami; Stephen S Hecht
Journal:  Head Neck       Date:  2012-07-17       Impact factor: 3.147

6.  Evidence supporting product standards for carcinogens in smokeless tobacco products.

Authors:  Dorothy K Hatsukami; Irina Stepanov; Herb Severson; Joni A Jensen; Bruce R Lindgren; Kimberly Horn; Samir S Khariwala; Julia Martin; Steven G Carmella; Sharon E Murphy; Stephen S Hecht
Journal:  Cancer Prev Res (Phila)       Date:  2014-12-18

7.  Identification of adducts formed in the reactions of 5'-acetoxy-N'-nitrosonornicotine with deoxyadenosine, thymidine, and DNA.

Authors:  Pramod Upadhyaya; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2008-11       Impact factor: 3.739

8.  Formation, repair, and genotoxic properties of bulky DNA adducts formed from tobacco-specific nitrosamines.

Authors:  Lisa A Peterson
Journal:  J Nucleic Acids       Date:  2010-09-05

9.  Reduced nicotine content cigarettes and use of alternative nicotine products: exploratory trial.

Authors:  Dorothy K Hatsukami; Xianghua Luo; Laura Dick; Margarita Kangkum; Sharon S Allen; Sharon E Murphy; Stephen S Hecht; Peter G Shields; Mustafa al'Absi
Journal:  Addiction       Date:  2016-11-02       Impact factor: 6.526

10.  Nornicotine nitrosation in saliva and its relation to endogenous synthesis of N'-nitrosonornicotine in humans.

Authors:  Aleksandar Knezevich; John Muzic; Dorothy K Hatsukami; Stephen S Hecht; Irina Stepanov
Journal:  Nicotine Tob Res       Date:  2012-08-24       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.